Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy

doi:10.3748/wjg.v23.i2.265

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8024)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

619

WORD

258

HTML

3915

Figures (1-3)

174

Tables (1-4)

148

Sum=5114

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

996

Download

1914

Sum=2910

Jan 14, 2017 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jan 14, 2017; 23(2): 265-274
Published online Jan 14, 2017. doi: 10.3748/wjg.v23.i2.265

Table 1 Clinicopathologic characteristics of 52 patients undergoing total pancreatectomy

Variable	No. of patients
Mean age ± SD (yr)	60.3 ± 9.0
Sex (male)	32
Pathology
Adenocarcinoma	43
Cystadenocarcinoma	2
Invasive IPMN	4
Acinar adenocarcinoma	1
Adenosquamous carcinoma	1
Renal cell carcinoma metastasis	1
Tumor location
Head	28
Corpus	15
Tail	3
> 1 location	6
Median primary tumor size (IQR) (cm)	4.7 (3.0-6.0)
Venous invasion	26
Lymph node invasion	18
Splenectomy	11
Operative time (IQR) (min)	472.5 (421.3-548.8)
Operative arrangement
Planned	20
Unplanned	32
Postoperative complication¹
Gastroplegia	4
Gastrointestinal or abdominal hemorrhage bleeding	1
Pneumonia	14
Abdominal infection	9
Hepatic failure	1
Respiratory failure	1
Length of postoperative hospital stay (IQR) (d)	12.0 (10.0-17.8)
Neoadjuvant treatment	14
Adjuvant treatment	52
Median recurrence-free time (IQR) (mo)	4.7 (2.7-13.6)
Median survival time (IQR) (mo)	20.9 (10.2-51.0)
1-year survival (%)	63.4
3-year survival (%)	24.2
5-year survival (%)	12.5

¹Five patients had two complications simultaneously, and one patient had three complications simultaneously. IPMN: Intraductal papillary mucinous neoplasms.

Table 2 Changes in biochemical data after total pancreatectomy

	Preop	Postop¹	Postop 1 mo	Postop 3 mo	Postop 6 mo	Postop 12 mo	P value²
FBG (mg/dL)	130 ± 60	154 ± 39	153 ± 84	167 ± 94	149 ± 68	142 ± 79	0.078
HbA1c (%)	6.7 ± 1.5	/	6.7 ± 0.8	7.2 ± 1.0	6.8 ± 0.8	6.5 ± 0.8	0.330
BMI (kg/m²)	22.3 ± 3.2	/	21.2 ± 3.0	20.6 ± 2.8	20.3 ± 3.0	19.6 ± 2.5	0.001
Total protein (g/L)	65.7 ± 9.2	60.4 ± 6.6	68.4 ± 5.8	66.4 ± 4.9	67.2 ± 8.5	67.8 ± 6.3	0.369
Albumin (g/L)	39.3 ± 4.0	38.0 ± 4.2	38.2 ± 4.0	36.2 ± 4.4	38.0 ± 7.7	38.8 ± 4.6	0.933
Prealbumin (mg/L)	203.9 ± 54.3	171.6 ± 40.8	135.3 ± 34.6	147.9 ± 42.0	145.9 ± 48.8	148.2 ± 54.6	0.001
PNI	46.0 ± 3.4	47.8 ± 6.3	44.6 ± 4.0	43.8 ± 5.9	42.7 ± 5.9	47.3 ± 4.8	0.244

¹The postoperative data are mean values calculated from biochemical data in the first 3 d after surgery;

²Paired t-test, mean ± SD, Preop vs Postop 12 mo. FBG: Fasting blood glucose; BMI: Body mass index; PNI: Prognostic nutritional index; Postop: Postoperative.

Table 3 Factors for complications, recurrence-free and overall survival after total pancreatectomy

Variable	Multivariate analysis
Variable	Odds ratio/hazard ratio	95%CI	P value
Complications
Postop FBG¹
< 155 mg/dL
≥ 155 mg/dL	4.074	1.188-13.965	0.025
Postop prealbumin¹
> 185 mg/L
≤ 185 mg/L	3.816	1.110-13.122	0.034
Recurrence-free survival
Preop FBG
≤ 110 mg/dL
> 110 mg/dL	2.330	1.204-4.510	0.012
Venous invasion
No
Yes	2.975	1.502-5.892	0.002
Postop HbA1c¹
< 7%
≥ 7%	2.655	1.299-5.425	0.007
Postop PNI¹
> 45
≤ 45	1.760	0.897-3.455	0.100
Overall survival
Diabetes mellitus
No
Short-term	0.943	0.300-2.965	0.920
Long-term	2.305	0.560-9.483	0.247
Preop FBG
≤ 110 mg/dL
> 110 mg/dL	1.112	0.357-3.462	0.854
Postop HbA1c²
< 7%
≥ 7%	3.212	1.147-8.999	0.026
Postop total protein²
> 55 g/L
≤ 55 g/L	1.152	0.304-4.364	0.835
Postop albumin²
> 35 g/L
≤ 35 g/L	2.894	0.551-15.195	0.209
Postop prealbumin²
> 185 mg/L
≤ 185 mg/L	3.961	0.976-16.068	0.054
Postop PNI²
> 45
≤ 45	1.143	0.242-5.408	0.866

¹Postoperative data were the latest biochemical values obtained during the last follow-up before tumor recurrence;

²Postoperative data were the latest biochemical values obtained during the last follow-up before patient death. FBG: Fasting blood glucose; PNI: Prognostic nutritional index.

Table 4 Preoperative factors for postoperative glycemic control and changes in body mass index after total pancreatectomy

Variable	Multivariate analysis
Variable	Odds ratio/B	95%CI/SE	P value
Postoperative glycemic control¹
Diabetes mellitus
No
Short-term	0.760	0.187-3.097	0.702
Long-term	15.019	1.278-176.211	0.031
Preop HbA1c
< 6.5%	1
≥ 6.5%	1.566	0.293-8.375	0.600
Changes in BMI¹
Age (yr)	-1.010	0.733	0.175
Alcohol history, yes or no	1.985	0.860	0.025

¹Postoperative data were the latest biochemical values obtained during the last follow-up. BMI: Body mass index.

Citation: Shi HJ, Jin C, Fu DL. Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy. World J Gastroenterol 2017; 23(2): 265-274
URL: https://www.wjgnet.com/1007-9327/full/v23/i2/265.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i2.265